CN102895492B - Drug for treating hyperlipidaemia - Google Patents
Drug for treating hyperlipidaemia Download PDFInfo
- Publication number
- CN102895492B CN102895492B CN 201210444543 CN201210444543A CN102895492B CN 102895492 B CN102895492 B CN 102895492B CN 201210444543 CN201210444543 CN 201210444543 CN 201210444543 A CN201210444543 A CN 201210444543A CN 102895492 B CN102895492 B CN 102895492B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- drug
- treatment
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a drug for treating hyperlipidaemia. The drug is prepared from the following medicinal raw materials in parts by weight:10-20 parts of herba hedyotis, 20-30 parts of cortex dictamni, 10-30 parts of herba orostachyos, 20-50 parts of schisandra chinensis, 5-15 parts of bulbus fritillariae pallidiflorae, 5-15 parts of Chinese osbeckia herb, 5-10 parts of radix rubiae, 10-20 parts of cortex mori, 10-20 parts of stamen nelumbinis, 1-10 parts of albizia julibrissin, 5-15 parts of euphobia lunulata, 10-20 parts of herba centipedae, 10-20 parts of herba ecliptae, 10-20 parts of white paeony root and 5-15 parts of honeysuckle. The drug for treating hyperlipidaemia is prepared from natural medicinal raw materials, and thereby having the advantages of quick acting, good curative effect and no toxic or side effects.
Description
Technical field
The present invention relates to clinical field, specifically, relate to a kind of medicament for the treatment of hyperlipemia.
Background technology
Hyperlipemia is atherosclerotic material base and principal element, is the risk factor of diseases such as coronary heart disease, hypertension.Studying the method for the treatment of hyperlipemia effectively clinically always.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of hyperlipemia.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of hyperlipemia, it is to be made by weight by following bulk drugs: Herba Hedyotidis Diffusae 10-20 part, Cortex Dictamni 20-30 part, Herba Orostachyos 10-30 part, Fructus Schisandrae Chinensis 20-50 part, Bulbus Fritillariae Pallidiflorae 5-15 part, Radix Osbeckiae Crinitae 5-15 part, Radix Rubiae 5-10 part, Cortex Mori 10-20 part, Stamen Nelumbinis 10-20 part, Flos Albiziae 1-10 part, Herba euphorbiae lunulatae 5-15 part, Herba Centipedae 10-20 part, Herba Ecliptae 10-20 part, Radix Paeoniae Alba 10-20 part and Flos Lonicerae 5-15 part.
Preferably, it is to be made by weight by following bulk drugs: 10 parts of 15 parts of Herba Hedyotidis Diffusaes, 25 parts of Cortex Dictamni, 20 parts of Herba Orostachyos, 30 parts of Fructus Schisandrae Chinensis, 10 parts of Bulbus Fritillariae Pallidifloraes, 10 parts of Radix Osbeckiae Crinitae, 8 parts in Radix Rubiae, 15 parts of Cortex Mori, 15 parts of Stamen Nelumbiniss, 5 parts of Flos Albiziaes, 10 parts of Herba euphorbiae lunulataes, 15 parts of Herba Centipedae, 15 parts of Herba Ecliptaes, 15 parts of the Radix Paeoniae Albas and Flos Loniceraes.
Preferably, described medicament is tablet, dispersible tablet, instant, powder or granule.
Use natural drug in the medicament for the treatment of hyperlipemia of the present invention, so its advantage that has instant effect, good effect, has no side effect.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get Herba Hedyotidis Diffusae 150 grams, Cortex Dictamni 250 grams, Herba Orostachyos 200 grams, Fructus Schisandrae Chinensis 300 grams, Bulbus Fritillariae Pallidiflorae 100 grams, Radix Osbeckiae Crinitae 100 grams, Radix Rubiae 80 grams, Cortex Mori 150 grams, Stamen Nelumbinis 150 grams, Flos Albiziae 50 grams, Herba euphorbiae lunulatae 100 grams, Herba Centipedae 150 grams, Herba Ecliptae 150 grams, the Radix Paeoniae Alba 150 grams and Flos Lonicerae 100 grams, pulverize, cross 100 mesh sieves, add sucrose 400 grams then, mixing, uniform distribution are packed in 200 bags namely.
Experimental example
Diagnostic criteria
With reference to the clinical research guideline of hyperlipemia " new Chinese medicine treatment " (the Zheng Xiao cornel. study of tcm new drug clinical guidance principle [S]. Beijing: Chinese Medicine science and technology publishing house, 2002:85) and national dyslipidemia in 2007 visit and control " China adult dyslipidemia guideline of prevention and treatment " and u.s. national cholesterol education program (NCEP) the adult treatment expert group (ATP) that the countermeasure group writes and (ATP-III) draft about the guide (the 3rd edition) of cholesterol reducing control CHD.The patient surveys blood fat and meets one of following situation person and can make a definite diagnosis: (1) cholesterol (TC) 〉=1.7mmol/L; Low density lipoprotein, LDL (LDL-C) 〉=3.6mmol/L; High density lipoprotein (HDL-C)≤1.0mmol/L.
The selector 40 routine hyperlipidemia patients of the standard of stating that close, male 20 examples, women 20 examples, the mean age is 48 years old.
Use the powder that makes among the embodiment 1 to treat, wherein one day 2 times, each one bag, treating 30 days is a course for the treatment of, treats 2 courses for the treatment of continuously.
Criterion of therapeutical effect
Reference " the clinical research guideline of new Chinese medicine treatment hyperlipemia " (the Zheng Xiao cornel. study of tcm new drug clinical guidance principle [S]. Beijing: Chinese Medicine science and technology publishing house, 2002:85) draft.Cure: treatment back lipids detection recovers normal; Produce effects; Treatment back lipids detection reaches following any 1 person, and namely TC descends 〉=20%, or TG decline 〉=40%, or HDL-C rising 〉=0.26mmol/L, or HDL-C/LDL-C 〉=20%; Effectively: treatment back lipids detection reaches following any 1 person, and namely TC descends＜20%, or TG decline 〉=20%＜40%, HDL-C rising 〉=0.104mmol/L＜0.26mmol/L, or HDL-C/LDL-C 〉=10%＜20%; Invalid: treatment back lipids detection does not have obvious improvement or improvement does not reach effective standard person.
Through treatment inspection patient's blood fat, find cholesterol (TC)＜1.5mmol/L of all patients; Low density lipoprotein, LDL (LDL-C)＜3.5mmol/L; High density lipoprotein (HDL-C) is 1.2-2.0mmol/L, all meets normal blood lipids index clinically.Therefore as seen, all patients all meet the standard of healing.
In therapeutic process the patient is followed up a case by regular visits to, all patients do not find tangible untoward reaction.
Claims (1)
1. medicament for the treatment of hyperlipemia, it is characterized in that it is to be made by weight by following bulk drugs: 10 parts of 15 parts of Herba Hedyotidis Diffusaes, 25 parts of Cortex Dictamni, 20 parts of Herba Orostachyos, 30 parts of Fructus Schisandrae Chinensis, 10 parts of Bulbus Fritillariae Pallidifloraes, 10 parts of Radix Osbeckiae Crinitae, 8 parts in Radix Rubiae, 15 parts of Cortex Mori, 15 parts of Stamen Nelumbiniss, 5 parts of Flos Albiziaes, 10 parts of Herba euphorbiae lunulataes, 15 parts of Herba Centipedae, 15 parts of Herba Ecliptaes, 15 parts of the Radix Paeoniae Albas and Flos Loniceraes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210444543 CN102895492B (en) | 2012-11-09 | 2012-11-09 | Drug for treating hyperlipidaemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210444543 CN102895492B (en) | 2012-11-09 | 2012-11-09 | Drug for treating hyperlipidaemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102895492A CN102895492A (en) | 2013-01-30 |
| CN102895492B true CN102895492B (en) | 2013-10-02 |
Family
ID=47568178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210444543 Expired - Fee Related CN102895492B (en) | 2012-11-09 | 2012-11-09 | Drug for treating hyperlipidaemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102895492B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524382A (en) * | 2014-12-25 | 2015-04-22 | 张群 | Effective component composition of traditional Chinese medicines for treating hyperlipemia and preparation method of composition |
-
2012
- 2012-11-09 CN CN 201210444543 patent/CN102895492B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102895492A (en) | 2013-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102430071B (en) | Medicament for treating herpes zoster | |
| CN102895492B (en) | Drug for treating hyperlipidaemia | |
| CN101032598B (en) | Expectorant cough suppressant and anti-asthmatic healthy wine | |
| CN103705846B (en) | The Chinese medicine preparation for the treatment of ovarian cyst | |
| CN102139051A (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN103041251A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
| CN103623242B (en) | Medicament for treating hyperlipemia on inspection | |
| CN102327398A (en) | Traditional Chinese medicine for treating diabetic cutaneous pruritus | |
| CN103550542B (en) | A kind of Clinical Laboratory is used for the treatment of the medicament of hyperlipemia | |
| CN102755424B (en) | A kind of oral medicinal liquor for the treatment of sciatica | |
| CN101850101B (en) | Chinese medicinal composition for treating metrostaxis and preparation method thereof | |
| CN103272186B (en) | Traditional Chinese medicine for curing curettage amenorrhea | |
| CN102743686A (en) | Pelvic inflammation-clearing capsule | |
| CN102488797B (en) | Medicinal composition for treating dysmenorrhea | |
| CN102552503B (en) | Traditional Chinese medicine powder used for treating cervical erosion | |
| CN102579789B (en) | Medicine for treating eczema | |
| CN102389560B (en) | Traditional Chinese medicine used for treating epidemic encephalitis type B | |
| CN104784504B (en) | A kind of preparation method for the treatment of the medicament of hyperlipemia | |
| CN101843718B (en) | Chinese medicament for treating lupus erythematosus | |
| CN103142977A (en) | Medicament for treating dysmenorrhea | |
| CN103816272B (en) | Method for preparing medicine treating intercondylar fracture of humerus | |
| CN104815132A (en) | External lotion for treating low back and leg pain and preparation method | |
| CN103285109A (en) | Chinese herbal medicine for treating bone fracture and preparation method thereof | |
| CN102552545B (en) | New application of medicinal composition | |
| CN102772544B (en) | A kind of cream drug for the treatment of scrotum scabies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131002 Termination date: 20161109 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |